High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Tuberculosis

Original research

High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Arbiv OA, Kim JM, Yan M, et al

High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis

Thorax 2022;77:1210-1218.